You’ve probably seen the news that Eli Lilly will begin selling Zepbound in vials by mail. What you...
Weighing in on Lilly’s tirzepatide vials
Medscape wonders how Lilly’s making tirzepatide available in vials will affect the GLP-1 market. Eli Lilly, of course, spewed its usual fearmongering about compounded versions, but Scott didn’t rise to the bait, but did point out that actually helping patients is a welcome change for Lilly.
